It takes a village to grow leukemia

Sarah Elitzur, Shai Izraeli

Research output: Contribution to journalArticlepeer-review


In this issue of Blood, Barz et al identified NT5C2 thiopurine resistance mutations in 16% of children with relapsed B-cell acute lymphoblastic leukemia (B-ALL). Despite the fact that most of the mutations were subclonal, their presence was associated with an inferior outcome. Strikingly, NT5C2-mutated cells were sensitive to relapse therapy, suggesting a complex association between NT5C2 mutations and the poor prognosis of relapsed ALL.

Original languageEnglish
Pages (from-to)886-887
Number of pages2
Issue number12
StatePublished - 19 Mar 2020
Externally publishedYes


Dive into the research topics of 'It takes a village to grow leukemia'. Together they form a unique fingerprint.

Cite this